Clinical trials recruiting for Mild Cognitive Impairment (MCI)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| KDS2010 | 1 |
| Lecanemab 10 mg/kg | 1 |
| natural product combination-1 (NPC1) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 3 |
| Arizona | 2 |
| Alabama | 1 |
| California | 1 |
| Maryland | 1 |
| Missouri | 1 |
| New York | 1 |
| Oklahoma | 1 |
Top cities
Self-screener
Recruiting trials
- A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
- China Cognition and Aging Study
- Community-based Screening for Alzheimer's Disease
- Comprehensive Assessment of Neurodegeneration and Dementia
- Crownlands Observing Progression With Neurons Study
- Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors
- Early-Stage Partner in Care Living Alone Plus
- Effects of Real vs. Soundless Acoustic Stimulation During Deep Sleep on Brain Activity, Memory, and Blood Biomarkers in Older Adults (60-85) With Mild Memory Impairment
- Genetic Studies of Early-onset Dementia
- Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort
- Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
- InRAD Observational Study
- Mindfulness for Cognition in Early-stage Alzheimer's Disease
- Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function
- Predicting Pre-dementia
- Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab
- Remote Sensing for ADRD-Specific Activities Identification in Older Adults
- Saliva and Extracellular Vesicles for Neurodegenerative Diseases
- Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
- The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment
- The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
- Time Restricted Eating in Alzheimer's Disease
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
- Using Light Therapy for Mild Cognitive Impairment
- Validation of a Digital Intervention to Rehabilitate Cognitive Resources
- rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression
Related conditions
Trials recruiting for Mild Cognitive Impairment (MCI) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Mild Cognitive Impairment (MCI) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.